O
Oliver A. Cornely
Researcher at University of Cologne
Publications - 638
Citations - 35879
Oliver A. Cornely is an academic researcher from University of Cologne. The author has contributed to research in topics: Medicine & Voriconazole. The author has an hindex of 81, co-authored 541 publications receiving 27426 citations. Previous affiliations of Oliver A. Cornely include Sheba Medical Center & University of Bonn.
Papers
More filters
Journal ArticleDOI
Essentials in Candida bloodstream infection.
TL;DR: A mini-review of the published literature to highlight important and often missed opportunities in the management of Candida bloodstream infection and recommend further efforts to increase the adherence to the essentials.
Journal ArticleDOI
Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope ® registry and from the literature
Jannik Stemler,Jon Salmanton-García,Danila Seidel,Barbara D. Alexander,Hartmut Bertz,Martin Hoenigl,Martin Hoenigl,Raoul Herbrecht,Lisa Meintker,Arne Meißner,Sibylle C. Mellinghoff,Ertan Sal,Marouan Zarrouk,Philipp Koehler,Oliver A. Cornely +14 more
TL;DR: The new Rasamsonia spp.
Journal ArticleDOI
Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection.
Vimalanand S. Prabhu,Oliver A. Cornely,Yoav Golan,Erik R. Dubberke,Sebastian M. Heimann,Mary E. Hanson,Jane Liao,Alison Pedley,Mary Beth Dorr,Stephen Marcella +9 more
TL;DR: Bezlotoxumab-treated inpatients experienced fewer CDI-associated readmissions compared with placebo-treatedInpatients, notably in participants aged ≥65 years and with severe CDI.
Prospective clinical evaluation of a LightCycler TM -mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer
Dieter Buchheidt,Margit Hummel,Dietlind Schleiermacher,Birgit Spiess,Rainer Schwerdtfeger,Oliver A. Cornely,S Wilhelm,Stefan Reuter,Innere Medizin +8 more
TL;DR: In patients at high risk for IA, positive results for Aspergillus by PCR of blood samples are highly suggestive for IA and contribute to the diagnosis, lacking discrimination by quantification across the different clinical categories.
Posted ContentDOI
The SARS-CoV-2 spike protein primes inflammasome-mediated interleukin-1- beta secretion in COVID-19 patient-derived macrophages
Sebastian J. Theobald,Alexander Simonis,Christoph Kreer,Matthias Zehner,Julia Fischer,Marie-Christine Albert,Jakob J Malin,Jessica Gräb,Sandra Winter,Ute Sandaradura de Silva,Boris Böll,Philipp Kohler,Henning Gruell,Isabelle Suárez,Michael Hallek,Gerd Fätkenheuer,Norma Jung,Oliver A. Cornely,Clara Lehmann,Hamid Kashkar,Florian Klein,Jan Rybniker +21 more
TL;DR: It is shown that the SARS-CoV-2 spike protein primes inflammasome activation and interleukin 1-beta (IL-1β) secretion in macrophages derived from COVID-19 patients but not in Macrophages from healthy Sars-Cov-2 naïve controls.